Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases
about
Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label studySignificance of soluble lectin-like oxidized LDL receptor-1 levels in systemic and coronary circulation in acute coronary syndrome.MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population.Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Potential benefits of berberine in the management of perimenopausal syndrome.Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals.Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology.Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial CellsPlasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on atherogenicity.Berberine and Its Role in Chronic Disease.Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress.Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack.
P2860
Q28830600-36B4A5E3-168C-4982-B50A-0AC434B5342DQ33660782-200F0908-7234-4716-B48A-1C080073286BQ33724036-C34D8EA8-8EE9-4C53-83EB-42FD67144C48Q33752266-5FD4A13C-7BF4-4EB6-8726-0FB64BE54073Q34072528-2AAD6D62-9689-4B94-8C5C-A3A0E2B8B08CQ35138347-88732875-B22B-4784-A5C5-165479F0DF05Q36049150-5D942D5F-5784-4D3D-9BF1-17E9C2005AD3Q36316432-0A04E7D1-E62D-4B6A-8C60-20CFD4467A61Q38248729-6792E8E1-7C01-47EE-9CF2-364A185E9AC4Q38825625-79B3026B-A7A9-47C0-818E-1763A970265AQ38907279-06338237-0660-4615-977B-40E0B3C0BE12Q38965186-8FEB530D-2730-4438-881F-F93281039584Q46874888-07F64BC7-853B-426B-9B09-A7B3AE2FF4E0Q50059271-B15331D0-8B54-469D-BB7A-1AEF15BC1E1C
P2860
Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@ast
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@en
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@nl
type
label
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@ast
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@en
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@nl
prefLabel
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@ast
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@en
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@nl
P2860
P921
P3181
P356
P1433
P1476
Soluble lectin-like oxidized l ...... herosclerosis-related diseases
@en
P2093
Alberico Luigi Catapano
Angela Pirillo
P2860
P304
P3181
P356
10.1155/2013/716325
P407
P577
2013-09-30T00:00:00Z